Topic: Health
Researchers at NIH found that a type of weight loss drug called GLP-1 affects brain cells in different ways. This helps explain why these pills work differently for each person and why their effects often slow down over time.
Scientists have been studying how GLP-1 receptor agonists, like Ozempic and Wegovy, affect our brains. These drugs help reduce appetite and promote weight loss. But until now, researchers didn't fully understand what happens inside the brain cells that these medications target.
The team at NIH used special imaging techniques to study how semaglutide, a type of GLP-1 drug, affects living brain tissue from mice. They found that the drug's impact depends on increased levels of cAMP in the area postrema, a part of the brain involved in appetite regulation.
However, not all brain cells responded equally to the drug. Some cells maintained elevated cAMP levels for longer periods while semaglutide was present, while others showed only temporary increases. The researchers believe that some cells may reduce their response by internalizing or breaking down GLP-1 receptors.
The team also tested whether they could prolong these signals. They found that using the drug roflumilast to block PDE4, an enzyme that breaks down cAMP, shifted more neurons toward a longer-lasting response.
Why It Matters
This research is important because it helps us understand why some weight loss pills stop working over time. This could lead to the development of new treatments that help people achieve and maintain a healthy weight.
Key Facts
- Researchers at NIH studied how GLP-1 receptor agonists affect brain cells in mice.
- The team found that semaglutide's impact depends on increased levels of cAMP in the area postrema, a part of the brain involved in appetite regulation.
- Not all brain cells responded equally to the drug.
- The researchers believe that some cells may reduce their response by internalizing or breaking down GLP-1 receptors.
Key Terms
- cAMP
- A molecule that helps regulate cellular signals
Implications
This research is important because it helps us understand why some weight loss pills stop working over time. This could lead to the development of new treatments that help people achieve and maintain a healthy weight.
Source: https://www.sciencedaily.com/releases/2026/05/260525000453.htm
Journal Reference:
- Claire Gao, Isabelle C. Geneve, Shakira Rodriguez-Gonzalez, Chia Li, Kaitlyn McElhern, Marc L. Reitman, Andrew Lutas, Michael J. Krashes. Semaglutide drives weight loss through cAMP-dependent mechanisms in GLP1R-expressing hindbrain neurons. Nature Metabolism, 2026; DOI: 10.1038/s42255-026-01534-8
Leave a Comment